Latest in Drugmakers

Sort by

2 items

UK promises rapid review of NHS drug-pricing rebate

Under the scheme, drugmakers discount the price of medicines sold in bulk to the healthcare system
Financial Times - 2d
Trump spares drugmakers from tariffs; costs could still go up

President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” tariffs; however, the global drug market may still be hit by ...
The Hill - 1d